MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Natus Medical Company Profile (NASDAQ:BABY)

Consensus Ratings for Natus Medical (NASDAQ:BABY) (?)
Ratings Breakdown: 1 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $39.00 (5.01% upside)

Analysts' Ratings History for Natus Medical (NASDAQ:BABY)
Show:
DateFirmActionRatingPrice TargetActions
4/21/2016Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Raymond JamesDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Natus Medical (NASDAQ:BABY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/20/2016        
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2015Q414$0.39$0.40$93.28 million$94.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012$0.11$0.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$0.05$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2012$0.12$0.14ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$0.06$0.07ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011$0.18$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$0.11$0.13ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Natus Medical (NASDAQ:BABY)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.29$0.32$0.31
Q2 20161$0.35$0.35$0.35
Q3 20161$0.41$0.41$0.41
Q4 20161$0.53$0.53$0.53
Q1 20171$0.37$0.37$0.37
Q2 20171$0.39$0.39$0.39
Q3 20171$0.44$0.44$0.44
Q4 20171$0.58$0.58$0.58
(Data provided by Zacks Investment Research)
Dividend History for Natus Medical (NASDAQ:BABY)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Natus Medical (NASDAQ:BABY)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Natus Medical (NASDAQ:BABY)
DateHeadline
06/28/16 10:29 AMNatus Medical, Inc. :BABY-US: Earnings Analysis: Q1, 2016 By the Numbers : June 28, 2016 -
06/28/16 07:09 AMNatus Medical : to Present at Jefferies 2016 Healthcare Conference
06/26/16 07:57 AMNatus Medical Incorporated (NASDAQ:BABY) Shorts Decreased by 7.47% After Short Covering - Press Telegraph
06/24/16 02:43 PMNatus Medical Inc. versus Baxter International Inc. Head to Head Compare - CML News
06/22/16 07:51 PMNewborn Screening 2016 Global Market Manufacturing Cost and Professional Survey Market Research Report
06/22/16 02:44 PMNew-Born Screening Market : Share, Forecast and Demand 2015 – 2021
06/09/16 02:44 PMNatus Medical Inc. (NASDAQ:BABY) Fundamental Star Rating Report - CML News
06/07/16 02:46 PMITI Inc (NASDAQ:ITCI) increased 2.43%: Abbott Laboratories (NYSE:ABT), Natus Medical Inc. (NASDAQ:BABY ... - KC Register
06/06/16 08:09 PMNATUS MEDICAL INC. (NASDAQ:BABY) Financial Condition Compared to S&P 500 - CML News
06/06/16 11:02 AMNatus Medical Expands Share Repurchase Program by $20M - Nasdaq
06/06/16 05:54 AMNatus Medical Expands Share Repurchase Program by $20M -
06/05/16 02:42 PMNatus Medical Incorporated (NASDAQ:BABY) Sellers Increased By 6.38% Their Shorts - HNN
06/04/16 11:12 AMNatus Announces $20 Million Share Repurchase Program
06/03/16 08:16 AMNatus Reveals $20 Million Share Buyback Program - Natus Medical Incorporated (NASDAQ: BABY) revealed that its Board has approved an expansion of its existing stock buyback program, authorizing the repurchase of a maximum of an additional $20 million of its common stock. The company set an expiration date of June 1, 2017 to make use of the funds for purpose ...Full story available on Benzinga.com
06/02/16 07:05 AMNatus Medical, Inc. breached its 50 day moving average in a Bullish Manner : BABY-US : June 2, 2016 -
06/01/16 11:13 AMPax World Management LLC Decreased Stake in Becton Dickinson & Co. (NYSE:BDX) by $15.08 Million as Shares Rose - CCH Daily News - Pax World Management LLC Decreased Stake in Becton Dickinson & Co. (NYSE:BDX) by $15.08 Million as Shares RoseCCH Daily NewsIt also increased its holding in Natus Medical Inc. (NASDAQ:BABY) by 103,100 shares in the quarter, for a total of 373,900 shares, and has risen its stake in Legg Mason Inc. (NYSE:LM). Pax World Management Llc is a New Hampshire-based institutional ...and more »
06/01/16 11:13 AMHow Analysts Feel About Natus Medical Inc (NASDAQ:BABY)? - HNN - How Analysts Feel About Natus Medical Inc (NASDAQ:BABY)?HNNOut of 1 analysts covering Natus Medical (NASDAQ:BABY), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. Natus Medical has been the topic of 4 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Below is a ...and more »
06/01/16 06:00 AMNatus to Present at Jefferies 2016 Healthcare Conference - [GlobeNewswire] - PLEASANTON, Calif., June 01, 2016-- Natus Medical Incorporated today announced that Jim Hawkins, President and Chief Executive Officer, will present at the Jefferies 2016 Healthcare Conference in New York ...
05/30/16 09:04 PMStock Paining Investors: Natus Medical Inc. (NASDAQ:BABY) - HNN - Stock Paining Investors: Natus Medical Inc. (NASDAQ:BABY)HNNWhen a company shows a steady upwards earnings trend, it is a good indicator that the company will dominate companies with a more volatile earnings trend. Natus Medical Inc. (NASDAQ:BABY)'s trailing 12 months EPS is 1.14. Last year, their EPS growth ...and more »
05/27/16 01:45 PMHow Analysts Feel About Natus Medical Inc After Today's Huge Decline? - Wall Street Hints and News - How Analysts Feel About Natus Medical Inc After Today's Huge Decline?Wall Street Hints and NewsThe stock of Natus Medical Inc (NASDAQ:BABY) is a huge mover today! The stock decreased 2.92% or $0.96 during the last trading session, hitting $31.93. About 435,284 shares traded hands or 28.58% up from the average. Natus Medical Inc ...
05/24/16 01:35 PMNatus Medical Incorporated (NASDAQ:BABY) Sellers Increased By 10.49% Their Shorts - Wall Street Hints and News - Natus Medical Incorporated (NASDAQ:BABY) Sellers Increased By 10.49% Their ShortsWall Street Hints and NewsThe short interest to Natus Medical Incorporated's float is 3.73%. The stock is up 0.43% or $0.14 after the news, hitting $33 per share. About 34,119 shares traded hands. Natus Medical Inc (NASDAQ:BABY) has declined 18.96% since October 15, 2015 and is ...and more »
05/24/16 09:45 AMCASM: Zacks SCR Initiates Coverage of CAS Medical. -
05/18/16 01:40 PMHow Many Natus Medical Inc (NASDAQ:BABY)'s Analysts Are Bearish? - Wall Street Hints and News - How Many Natus Medical Inc (NASDAQ:BABY)'s Analysts Are Bearish?Wall Street Hints and NewsOut of 1 analysts covering Natus Medical (NASDAQ:BABY), 2 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 67% are positive. Natus Medical has been the topic of 4 analyst reports since July 23, 2015 according to StockzIntelligence Inc. Below is a ...and more »
05/13/16 07:34 AMTwo Buzzers to Observe: Natus Medical Incorporated (NASDAQ:BABY) , Rockwell Medical, Inc. (NASDAQ:RMTI) - Street Updates - Two Buzzers to Observe: Natus Medical Incorporated (NASDAQ:BABY) , Rockwell Medical, Inc. (NASDAQ:RMTI)Street UpdatesOn 5/12/2016, Natus Medical Incorporated (NASDAQ:BABY) ended trading session lower at $32.49 with +0.00%. The company traded a volume of 310.23 thousand shares as comparison to average volume of 425.35 thousand shares. During the 52 –week ...State Street Corp Bought A Little More Natus Medical Incorporated (BABY) StockFinance Dailyall 5 news articles »
05/10/16 07:16 AMNatus Medical Incorporated (NASDAQ:BABY) Sellers Covered 10.61% of Their Shorts - B.O.D.Y Confidential - Natus Medical Incorporated (NASDAQ:BABY) Sellers Covered 10.61% of Their ShortsB.O.D.Y ConfidentialThe short interest to Natus Medical Incorporated's float is 3.38%. The stock is up 2.18% or $0.7 after the news, hitting $32.84 per share. About 55,883 shares traded hands. Natus Medical Inc (NASDAQ:BABY) has declined 18.59% since October 1, 2015 and ...and more »
05/09/16 06:00 AMNatus to Present at UBS Global Healthcare Conference - [GlobeNewswire] - PLEASANTON, Calif., May 09, 2016-- Natus Medical Incorporated today announced that Jonathan Kennedy, Sr. Vice-President and Chief Financial Officer, will present at the UBS Global Healthcare Conference ...
05/06/16 07:27 AMInvestor News: Investigation over potential Wrongdoing at Natus Medical Inc (NASDAQ:BABY) - GroundReport - Investor News: Investigation over potential Wrongdoing at Natus Medical Inc (NASDAQ:BABY)GroundReportAn investigation for investors in NASDAQ:BABY shares was announced over potential breaches of fiduciary duties by certain Natus Medical directors. Investors who purchased shares of Natus Medical Inc (NASDAQ:BABY) have certain options and should ...
05/04/16 01:15 PMNATUS MEDICAL INC Files SEC form 10-Q, Quarterly Report -
04/27/16 08:43 AMA Director at Natus Medical Inc. (NASDAQ: BABY) is Selling Shares - Analyst Ratings - Web Breaking NewsA Director at Natus Medical Inc. (NASDAQ: BABY) is Selling SharesAnalyst RatingsYesterday, a Director at Natus Medical Inc. (NASDAQ: BABY), Doris Engibous, sold shares of BABY for $163.4k. In addition to Doris Engibous, 2 other BABY executives reported Sell trades in the last month. Based on Natus Medical Inc.`s latest earnings ...Natus Medical Inc (BABY) VP Kenneth M. Traverso Sells 7459 SharesWeb Breaking NewsNatus Medical Inc (BABY) Files Form 4 Insider Selling : Kenneth M Traverso Sells 7459 SharesMarket DigestKenneth Traverso, Natus Medical Inc (NASDAQ:BABY)'s insider Unloaded 7459 SharesThe PostCCH Daily Newsall 5 news articles »
04/26/16 08:15 AMNatus Medical (NASDAQ:BABY) & Adaptimmune Therapeutics PLC – (NASDAQ:ADAP) News Review - Wall Street 24 - Natus Medical (NASDAQ:BABY) & Adaptimmune Therapeutics PLC – (NASDAQ:ADAP) News ReviewWall Street 24On Friday, Shares of Natus Medical Inc (NASDAQ:BABY) gained 4.19% to $34.09. The share price is trading in a range of $32.46 – $34.12. The stock exchanged hands with 638,712 Million shares contrast to its average daily volume of 506,510 Million shares.and more »
04/26/16 08:14 AMNatus Medical Inc (BABY) Earnings Per Share Expected to Decline - The Post - Natus Medical Inc (BABY) Earnings Per Share Expected to DeclineThe PostWall Street await Natus Medical Inc (NASDAQ:BABY) to release earnings on April, 27. Analysts forecast earnings per share of $0.34, up exactly $0.03 or 9.68% from 2014's $0.31 EPS. The expected BABY's profit could reach $11.70 million giving the stock ...
04/25/16 07:55 AMWhat should one expect from: Natus Medical Inc (NASDAQ:BABY) - News Oracle - What should one expect from: Natus Medical Inc (NASDAQ:BABY)News OracleLast Trade: The Company rose 4.19% and finished at $34.09. The daily volume was measured at 638,712.00 shares. The 52-week high of the share price is $51.05 and the 52-week low is $29.34. The company has a market cap of $1.16 billion. The stock has ...and more »
04/22/16 08:30 PMATTENTION NATUS SHAREHOLDERS: Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Natus Medical Incorporated; Encourages Investors to Contact the Firm for Additional Information - [PR Newswire] - SAN DIEGO, April 22, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Natus Medical Incorporated (NASDAQ: BABY) ...
04/22/16 07:30 AMHagens Berman Investigates Natus Medical Inc.’s Guidance on Prepayments From the Venezuelan Government and the Timing of Insider Sales - [Business Wire] - Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating whether Natus Medical Incorporated. issued false and misleading statements about its expected receipt of prepayments under a contract with the Venezuelan Government and the timing of certain insiders’ stock sales, potentially in violation of the securities laws.
04/21/16 10:22 AMNatus Medical, Inc. :BABY-US: Earnings Analysis: Q1, 2016 By the Numbers -
04/21/16 08:21 AMVolatile Measures on Top- Medtronic (NYSE:MDT), Natus Medical (NASDAQ:BABY), AbbVie (NYSE:ABBV) - Seneca Globe - Volatile Measures on Top- Medtronic (NYSE:MDT), Natus Medical (NASDAQ:BABY), AbbVie (NYSE:ABBV)Seneca GlobeStocks of Natus Medical Inc. (NASDAQ:BABY) surged 5.70% to trade at $33.20 in last session with shares volume of 1.32 Million. Natus Medical Inc. (BABY) reported that first-quarter profit of $8.5 million. The Pleasanton, California-based firm stated it ...
04/20/16 03:32 PMNatus Medical Inc Says Adios to Venezuela Guidance - Revenue from the contract with the country becomes upside for the medical-device maker.
04/20/16 11:56 AMEdited Transcript of BABY earnings conference call or presentation 20-Apr-16 3:00pm GMT -
04/20/16 06:35 AMNatus Medical Inc Earnings Call scheduled for 11:00 am ET today -
04/20/16 06:07 AMQ1 2016 Natus Medical Inc Earnings Release - Time Not Supplied -
04/20/16 05:11 AMNatus Medical beats 1Q profit forecasts -
04/20/16 05:08 AM6:08 am Natus Medical beats by $0.04, reports revs in-line; guides Q2 EPS below consensus, revs in-line; adjusts FY16 guidance down based exclusion of $60 mln of Venezuela contract revenue -
04/20/16 05:00 AMNatus Medical Announces Record First Quarter 2016 Financial Results - [GlobeNewswire] - Record first quarter non-GAAP earnings per share of $0.34 Achieves non-GAAP gross margin of 63.1% Updates revenue and earnings guidance for the second quarter and fiscal year 2016 PLEASANTON, Calif., April ...
04/18/16 04:32 PM3 Things to Watch as Natus Medical Inc Reports Earnings - The revenue miss is important, but don't forget to focus on the future.
04/15/16 07:18 PMNATUS NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Natus Medical Inc. to Contact the Firm - [Business Wire] - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Natus Medical Inc. .
04/15/16 04:02 PMIMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Claims against Natus Medical Inc. and Advises Investors with Losses to Contact the Firm - [Business Wire] - Goldberg Law PC announces that it is investigating claims of potential misrepresentations by Natus Medical Inc. .
04/15/16 02:30 PMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation into Possible Securities Fraud Violations by Certain Officers and Directors of Natus Medical Inc. - [Business Wire] - Levi & Korsinsky announces it has commenced an investigation of Natus Medical Inc. concerning possible violations of federal securities laws.
04/15/16 12:13 PMINVESTOR ALERT: Investigation of Natus Medical Inc. Announced by Law Offices of Howard G. Smith - [Business Wire] - Law Offices of Howard G. Smith announces an investigation on behalf of investors of Natus Medical Inc. concerning the Company and its officers’ possible violations of federal securities laws.
04/12/16 11:23 AMNatus Medical Incorporated (NASDAQ:BABY) Sellers Increased By 36.68% Their Shorts - RiversideGazette.com - Natus Medical Incorporated (NASDAQ:BABY) Sellers Increased By 36.68% Their ShortsRiversideGazette.comThe short interest to Natus Medical Incorporated's float is 4%. The stock is down 0.40% or $0.12 after the news, hitting $30.25 per share. About 163,029 shares traded hands. Natus Medical Inc (NASDAQ:BABY) has declined 23.02% since September 2, 2015 ...
04/08/16 11:26 AMNatus Medical: A Strong Sell on Weak Q1 & Estimate Revision - Nasdaq - Natus Medical: A Strong Sell on Weak Q1 & Estimate RevisionNasdaqOn Apr 7, Zacks Investment Research downgraded Natus Medical Inc BABY - a provider of newborn care and neurology healthcare products - to a Zacks Rank #5 (Strong Sell). Why the Downgrade? The downgrade primarily reflects lackluster preliminary ...and more »
About Natus Medical

Natus Medical logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: BABY
  • CUSIP: 63905010
Key Metrics:
  • Previous Close: $37.14
  • 50 Day Moving Average: $34.29
  • 200 Day Moving Average: $36.60
  • P/E Ratio: 32.58
  • P/E Growth: 1.01
  • Market Cap: $1.21B
  • Current Quarter EPS Consensus Estimate: $1.64 EPS
Additional Links:
Natus Medical (NASDAQ:BABY) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha